Adamas Pharmaceuticals Inc. buy marge
Start price
07.09.17
/
50%
€19.52
Target price
09.04.19
€37.88
Performance (%)
-68.62%
End price
09.04.19
€6.12
Summary
This prediction ended on 09.04.19 with a price of €6.12. Massive losses of -68.62% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
| iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
| iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
| iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by marge for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
marge stimmt der Buy-Einschätzung von klostergang zu
marge stimmt am 07.09.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 32$ zu.
Überschrift: Adamas's ADS-5102 could become the first FDA approved drug for Parkinson's disease
(Vom Mitglied beendet)